|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM035464577 |
| 003 |
DE-627 |
| 005 |
20250126203553.0 |
| 007 |
tu |
| 008 |
231221s1986 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed25n0119.xml
|
| 035 |
|
|
|a (DE-627)NLM035464577
|
| 035 |
|
|
|a (NLM)3565192
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Sakashita, S
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections
|
| 264 |
|
1 |
|c 1986
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 27.04.1987
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The clinical efficacy of combination therapy using Cefoxitin (CFX) and Amikacin (AMK) was studied in 19 patients with complicated urinary tract infections. Patients received 2 g of CFX i.v. and 100 mg of AMK i.m. twice a day. The overall clinical efficacy of treatment was evaluated by the criteria proposed by the UTI Committee, Japan, as excellent, moderate or poor. The overall clinical efficacy was excellent in 89%, moderate in 5% and poor in 5% of the patients. Of the 21 strains isolated from the patients, 20 strains (95%) were eradicated. No subjective side effects were observed. Drug-related aggravation in laboratory tests were observed slight elevations of glutomic-oxalacefic transaminase, glutamic-pyruvic transaminase and alkaliphosphatase in 2 cases, but all of them were minimal and reversible. Underlying condition-related aggravation was observed a slight elevation of BUN and creatinine clearance in 1 case. These results suggest that the combination therapy with CFX and AMK might be useful in the treatment of complicated urinary tract infections
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Cefoxitin
|2 NLM
|
| 650 |
|
7 |
|a 6OEV9DX57Y
|2 NLM
|
| 650 |
|
7 |
|a Amikacin
|2 NLM
|
| 650 |
|
7 |
|a 84319SGC3C
|2 NLM
|
| 700 |
1 |
|
|a Shinno, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Asano, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tubo, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Imanaka, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Miyabe, N
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Nagamori, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Takahashi, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Koyanagi, T
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 32(1986), 10 vom: 15. Okt., Seite 1547-50
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnas
|
| 773 |
1 |
8 |
|g volume:32
|g year:1986
|g number:10
|g day:15
|g month:10
|g pages:1547-50
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 32
|j 1986
|e 10
|b 15
|c 10
|h 1547-50
|